NTLA

10.0005.04%
DJ

Derrick J. Rossi

Founder & Member of Scientific Advisor Board

Dr. Derrick J. Rossi, Ph.D. is Chief Executive Officer & Chairman of the Board of Convelo Therapeutics, Inc. Dr. Rossi serves as an Advisor at Nivien Therapeutics Company. Dr. Rossi co-founded Moderna Therapeutics in 2010, Intellia Therapeutics Inc. in 2015 and Magenta Therapeutics in 2016. He joined the IDI (now Program in Cellular and Molecular Medicine at Boston Children’s Hospital) in 2007 as a Junior Investigator. Dr. Rossi had been an Advisor of PureTech Health plc since October 13, 2016. He has been a Member of Scientific Advisor Board at Intellia Therapeutics Inc. since April 2015. He served as a Member of Scientific Advisory Board at Moderna Therapeutics, Inc. and served as its Director. He served as a Member of Scientific Advisory Board at Magenta Therapeutics, Inc. until December 7, 2017. He is an Investigator in the Program in Cellular and Molecular Medicine at Boston Children’s Hospital and is a Principal Faculty Member of the Harvard Stem Cell Institute. He is Faculty member of the Division of Hematology/Oncology in the Department of Medicine at Boston Children’s Hospital. He is an Associate Professor in the Department of Pediatrics at Harvard Medical School. He is an Associate Professor in the Department of Stem Cell and Regenerative Biology at Harvard Medical School and Harvard University. He is a hematopoietic stem cell expert who has made multiple important discoveries relevant to human health. He was named one of Time’s 100 Most Influential People in 2011. He has received multiple awards including the Pathways to Independence (PI) award from the NIH and a Robertson Investigator award from the New York Stem Cell Foundation. He trained as a Post-Doctoral Fellow at Stanford University from 2003 to 2007. Dr. Rossi received his B.Sc. and M.Sc. degrees from the University of Toronto, Canada in the 1990s and his Ph.D. from the University of Helsinki, Finland in 2003.

Positions